Article Text
Abstract
We have recently introduced a new item to our neurology Grand Rounds—the ‘1-3-5 presentation’. The format comprises a presentation on one topic, using three slides and lasting no more than 5 minutes. This a useful way of covering brief single topics and introducing and sparking discussion on more complex ones. ‘1-3-5s’ have proven popular in our department and we have compiled a library of these presentations that is hosted on a YouTube channel. This article discusses the benefits and prospects for this format and encourages other units to provide similar opportunities for teaching and learning among all clinical grades.
- CLINICAL NEUROLOGY
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Twitter @SarahJa22560586
VF and S-JM contributed equally.
Contributors Conceptualisation: S-JM and J-PL. All authors contributed equally to manuscript drafting and editing. S-JM and VF: YouTube channel management.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally reviewed by Richard Davenport, Edinburgh, UK and Matt Jones, Manchester, UK.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Read the full text or download the PDF:
Other content recommended for you
- Three new drugs for the prevention of migraine
- Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects
- Management of chronic migraine
- Chronic migraine
- TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine
- Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial
- Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
- Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway
- Migraine: mimics, borderlands and chameleons
- Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series